Some research carried out by myself,
Sequential Meetings:
It's common to have a Type C meeting early in development to address initial questions and then transition to Type B meetings as the product progresses toward specific milestones. For example, a sponsor might have a Type C meeting to discuss an initial concept for a new drug, then have a Type B meeting (e.g., pre-IND) to discuss clinical trial design after the initial concept is further developed.
- Forums
- ASX - By Stock
- Merck conundrum
IMM
immutep limited
Add to My Watchlist
3.92%
!
24.5¢

Some research carried out by myself,Sequential Meetings:It's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $357.7M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.5¢ | $351.4K | 1.410M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 311580 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 62453 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 311580 | 0.245 |
12 | 234126 | 0.240 |
5 | 183255 | 0.235 |
14 | 476425 | 0.230 |
7 | 98474 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 62453 | 5 |
0.255 | 78352 | 4 |
0.260 | 837488 | 8 |
0.265 | 433745 | 4 |
0.270 | 37000 | 1 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |